Previous studies by others reported that co-mutations on KRAS, CDKN2A, and/or CDKN2B (encoding p15 protein) accelerated tumorigenesis in mouse lung26 and human lung cancer patients at early stage27. This evidence concerns the gene CDKN2A and lung carcinoma.